GCG and type 2 diabetes mellitus: Although GLP-1 receptor agonists (GLP-1 RAs) have shown promising neuroprotective and cognitive effects in individuals with T2D and related metabolic dysfunctions, the growing off-label use of these drugs among healthy individuals, particularly for weight loss, raises important interpretative concerns.